(Reuters) - About one in eight adults have taken a drug belonging to the GLP-1 class of medications for weight loss and ...
A poll from the health policy nonprofit KFF found that 1 in 8 adults say they’ve taken a GLP-1 agonist, the obesity and ...
A new KFF health tracking survey found that one in eight U.S. adults have taken Ozempic or a similar GLP-1 drug at some point ...
KFF poll results suggest about 12 percent of adults in the U.S. have tried a GLP-1 drug like Ozempic to manage chronic health ...
JUST 6% OF US ... DRUGS THAN THOSE WITH PRIVATE INSURANCE. EXPERTS SAY THE LACK OF ACCESSIBILITY MEANS MANY PEOPLE TURN TO ...
The majority — 62 percent — said they were using the drugs to treat a chronic condition like diabetes or heart disease while ...
About 12% of American adults say they have used one of the increasingly popular weight loss and diabetes drugs known as ...
JUST 6% OF US ADULTS WITH DIABETES ... AND THOSE WHO CAN GET ACCESS TO THE DRUG SOMETIMES HAVE TO STOP BECAUSE OF About 1 in 8 adults in the United States has used a GLP-1 drug like Ozempic ...